Kiniksa Pharmaceuticals International Plc Stock Performance
as on March 25, 2026 at 6:59 am IST
Day's Low
Day's High
$44.43$45.75
0.98%
Downside
1.96%
Upside
52 Week's Low
52 Week's High
$18.26$49.1259.32%
Downside
9.47%
Upside
Kiniksa Pharmaceuticals International Plc share price movements today
- Previous Close
- $46.04
- Open
- $45.75
- Volume
- 337.5K
- Day's Low - High
- $44.43 - $45.75
- 52 Week Low - High
- $18.26 - $49.12
Kiniksa Pharmaceuticals International Plc Historical Returns
- 1 Month Return
- + 7.67 %
- 3 Month Return
- + 8.35 %
- 1 Year Return
- + 98.53 %
- 3 Year Return
- + 303.51 %
- 5 Year Return
- + 176.02 %
Kiniksa Pharmaceuticals International Plc Stock Fundamentals & Key Indicators
Check Kiniksa Pharmaceuticals International Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.5B
EPS (TTM)
1.2
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
5.50%
PE Ratio (TTM)
61.44
Industry PE ratio
-4.738881355932204
PEG Ratio
0EBITDA
78.8M
Revenue (TTM)
677.6M
Profit Margin
8.71%
Return On Equity TTM
11.73%
Kiniksa Pharmaceuticals International Plc Stock Valuation
Track how Kiniksa Pharmaceuticals International Plc P/E has moved over time to understand its valuation trends.
Kiniksa Pharmaceuticals International Plc in the last 5 years
Lowest (-174.01x)
September 30, 2024
Industry (-4.74x)
March 25, 2026
Today (61.44x)
March 25, 2026
Highest (177.55x)
March 31, 2024
Today’s Price to Earnings Ratio: 61.44x
Kiniksa Pharmaceuticals International Plc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kiniksa Pharmaceuticals International Plc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.5B | 176.02% | 61.44 | 8.71% | |
| BUY | $22.8B | NA | 18.7 | 41.94% | |
| HOLD | $15.2B | -5.21% | -21.95 | -24.58% | |
| BUY | $44.8B | NA | 20.55 | 15.11% | |
| BUY | $51.0B | -24.63% | 19.25 | 28.24% |
Stock Returns calculator for Kiniksa Pharmaceuticals International Plc Stock including INR - Dollar returns
The Kiniksa Pharmaceuticals International Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kiniksa Pharmaceuticals International Plc investment value today
Current value as on today
₹2,03,029
Returns
₹1,03,029
(+103.03%)
Returns from Kiniksa Pharmaceuticals International Plc Stock
₹93,489 (+93.49%)
Dollar Returns*
₹9,541 (+9.54%)
Analyst Recommendation on Kiniksa Pharmaceuticals International Plc Stock
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Kiniksa Pharmaceuticals International Plc. Average target price of $57.38
Kiniksa Pharmaceuticals International Plc Share Price Target
Get share price movements and forecasts by analysts on Kiniksa Pharmaceuticals International Plc.
What analysts predicted
21.8%UPSIDE
Target Price
$57.38
Current Price
$44.87
Analyzed by
11 Analysts
Target
$57.38
Kiniksa Pharmaceuticals International Plc target price $57.38, a slight upside of 21.8% compared to current price of $44.87. According to 11 analysts rating.
Kiniksa Pharmaceuticals International Plc Stock’s Investor Sentiment and Interest
Search interest for Kiniksa Pharmaceuticals International Plc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Kiniksa Pharmaceuticals International Plc Quarterly Profit & Loss
All numbers in Millions USD
Kiniksa Pharmaceuticals International Plc Annual Profit & Loss
All numbers in Millions USD
Kiniksa Pharmaceuticals International Plc Quarterly Cash Flow
All numbers in Millions USD
Kiniksa Pharmaceuticals International Plc Annual Cash Flow
All numbers in Millions USD
Insights on Kiniksa Pharmaceuticals International Plc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 8 quarters, 79.85M → 202.12M (in $), with an average increase of 12.2% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, KNSA stock has moved up by 98.5%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, KNSA has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, KNSA has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 18.43M → 14.19M (in $), with an average decrease of 23.0% per quarter
About Kiniksa Pharmaceuticals International Plc
| Organisation | Kiniksa Pharmaceuticals International Plc |
| Headquarters | 105 Piccadilly, London, United Kingdom, W1J 7NJ |
| Industry | Health Technology |
| CEO | Mr. Sanj K. Patel |
| E-voting on shares | Click here to vote |
Key Management of Kiniksa Pharmaceuticals International Plc
Name | Title |
|---|---|
Mr. Ross Michael Moat | COO & Principal Operating Officer |
Mr. Jonathan Kirshenbaum | Investor Relations Officer |
Mr. Mark A. Ragosa C.F.A. | Senior VP & CFO |
Dr. John F. Paolini FACC, M.D., Ph.D. | Executive VP & Chief Medical Officer |
Mr. Eben Tessari | Chief Strategy Officer |
Mr. Michael R. Megna CPA | Senior VP & Chief Accounting Officer |
Ms. Mei Jang | Senior VP & Chief Technical Officer |
Mr. Douglas Barry | Senior VP, Chief Legal Officer & Secretary |
Ms. Megan Woods M.B.A. | Senior VP & Chief Human Resources Officer |
Mr. Sanj K. Patel | CEO & Chairman of the Board |
FAQs
What is Kiniksa Pharmaceuticals International Plc share price today?
Kiniksa Pharmaceuticals International Plc share price today is $44.87 as on at the close of the market. Kiniksa Pharmaceuticals International Plc share today touched a day high of $45.75 and a low of $44.43.
What is the 52 week high and 52 week low for Kiniksa Pharmaceuticals International Plc share?
Kiniksa Pharmaceuticals International Plc share touched a 52 week high of $49.12 on and a 52 week low of $18.26 on . Kiniksa Pharmaceuticals International Plc stock price today i.e. is closed at $44.87,which is 8.65% down from its 52 week high and 145.80% up from its 52 week low.
What is Kiniksa Pharmaceuticals International Plc's market capitalisation today?
Kiniksa Pharmaceuticals International Plc market capitalisation is $0.00T as on .
How to invest in Kiniksa Pharmaceuticals International Plc Stock (KNSA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kiniksa Pharmaceuticals International Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kiniksa Pharmaceuticals International Plc Shares that will get you 0.0334 shares as per Kiniksa Pharmaceuticals International Plc share price of $44.87 per share as on March 25, 2026 at 1:29 am IST.
What is the minimum amount required to buy Kiniksa Pharmaceuticals International Plc Stock (KNSA) from India?
Indian investors can start investing in Kiniksa Pharmaceuticals International Plc (KNSA) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Kiniksa Pharmaceuticals International Plc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kiniksa Pharmaceuticals International Plc share’s latest price of $44.87 as on March 25, 2026 at 1:29 am IST, you will get 0.2229 shares of Kiniksa Pharmaceuticals International Plc. Learn more about
fractional shares .
What are the returns that Kiniksa Pharmaceuticals International Plc has given to Indian investors in the last 5 years?
Kiniksa Pharmaceuticals International Plc stock has given 176.02% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?